Ubs Group Ag Repligen Corp Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Repligen Corp stock. As of the latest transaction made, Ubs Group Ag holds 73,897 shares of RGEN stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,897

Previous 81,748 9.6%

Holding current value

$10.1 Million

Previous $15 Million 38.04%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$120.0 - $182.95 $942,120 - $1.44 Million	-7,851 Reduced 9.6%	73,897 $9.32 Million
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $8.01 Million - $9.78 Million	46,917 Added 134.7%	81,748 $15 Million
Q4 2023 Feb 09, 2024	BUY	$114.17 - $185.35 $606,356 - $984,393	5,311 Added 17.99%	34,831 $6.26 Million
Q3 2023 Nov 09, 2023	SELL	$138.78 - $176.51 $8.42 Million - $10.7 Million	-60,646 Reduced 67.26%	29,520 $4.69 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $4.75 Million - $6.18 Million	34,282 Added 61.34%	90,166 $12.8 Million
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $1.56 Million - $2 Million	10,101 Added 22.06%	55,884 $9.41 Million
Q4 2022 Feb 08, 2023	BUY	$162.42 - $220.56 $2.85 Million - $3.87 Million	17,526 Added 62.02%	45,783 $7.75 Million
Q3 2022 Nov 10, 2022	BUY	$160.42 - $256.21 $410,675 - $655,897	2,560 Added 9.96%	28,257 $5.29 Million
Q2 2022 Aug 10, 2022	SELL	$140.68 - $188.02 $450,176 - $601,664	-3,200 Reduced 11.07%	25,697 $4.17 Million
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $4.19 Million - $6.71 Million	-26,017 Reduced 47.38%	28,897 $5.44 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $1.45 Million - $1.79 Million	5,866 Added 11.96%	54,914 $14.5 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $1.61 Million - $2.68 Million	8,258 Added 20.25%	49,048 $14.2 Million
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $1.49 Million - $1.98 Million	-8,969 Reduced 18.02%	40,790 $8.14 Million
Q1 2021 May 12, 2021	SELL	$180.37 - $226.26 $1.23 Million - $1.55 Million	-6,837 Reduced 12.08%	49,759 $9.67 Million
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $236,631 - $330,098	1,598 Added 2.91%	56,596 $10.8 Million
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $2.77 Million - $3.58 Million	22,623 Added 69.88%	54,998 $8.12 Million
Q2 2020 Jul 31, 2020	SELL	$94.33 - $140.48 $884,249 - $1.32 Million	-9,374 Reduced 22.45%	32,375 $4 Million
Q1 2020 May 01, 2020	SELL	$84.96 - $109.14 $8.21 Million - $10.5 Million	-96,630 Reduced 69.83%	41,749 $4.03 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $761,438 - $959,840	-10,312 Reduced 6.94%	138,379 $12.8 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $9.2 Million - $11.5 Million	120,004 Added 418.32%	148,691 $11.4 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $861,021 - $1.37 Million	-15,886 Reduced 35.64%	28,687 $2.47 Million
Q1 2019 May 14, 2019	SELL	$49.45 - $62.8 $5.56 Million - $7.06 Million	-112,361 Reduced 71.6%	44,573 $2.63 Million
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $6.23 Million - $8.89 Million	129,049 Added 462.79%	156,934 $8.28 Million
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $5,850 - $7,371	125 Added 0.45%	27,885 $1.55 Million
Q2 2018 Aug 14, 2018	SELL	$35.26 - $47.04 $1.1 Million - $1.47 Million	-31,170 Reduced 52.89%	27,760 $1.31 Million
Q1 2018 May 15, 2018	BUY	$30.92 - $37.27 $1.49 Million - $1.79 Million	48,051 Added 441.69%	58,930 $2.13 Million
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $670,931 - $802,725	-20,625 Reduced 65.47%	10,879 $395,000
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $43,599 - $54,304	1,179 Added 3.89%	31,504 $1.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	18,989 Added 167.51%	30,325 $1.26 Million
Q1 2017 Nov 14, 2017	BUY	N/A	11,336	11,336 $399,000

Others Institutions Holding RGEN

# of Institutions

496

Shares Held

53.9M

Call Options Held

420K

Put Options Held

85.3K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account